Skip to main content

Table 3 Number of patients on different types of biologic agents

From: Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates

Biologic

Number of Patients

%

Etanercept

41

33%

Adalimumab

43

35%

Tocilizumab

24

20%

Abatacept

5

4%

Canakinumab

4

3%

Anakinra

5

4%

Rituximab

2

1.60%

Infliximab

2

1.6%

Total

126

 
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096